Using non-invasive skin detection technology to evaluate the efficacy and barrier function of chemical exfoliation in the treatment of mild to moderate acne: a randomized controlled trial.

Using non-invasive skin detection technology to evaluate the efficacy and barrier function of chemical exfoliation in the treatment of mild to moderate acne

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034462

Enrollment

Unknown

Registered

2020-07-05

Start date

2020-07-01

Completion date

Unknown

Last updated

2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Interventions

Experimental group:AHAs (35%)

Experimental group:Salicylic acid (30%)

Experimental group:Salicylic acid (20%)+AHAs (10%)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age:18-40,both gender; 2. Meet the diagnostic criteria for mild to moderate acne; 3. Have not used any cosmetic treatment (laser, chemical exfoliation) in the first 6 months, and have not used any topical or oral medication to treat acne in the first 3 months; 4. No contraindications for use of chemical exfoliation treatment; 5. Complete the whole study according to the requirements of the study and can follow up as required; 6. The informed consent has been signed and willing to complete the research process.

Exclusion criteria

Exclusion criteria: 1. Facial combined with herpes infection, infectious soft warts, common warts and other diseases, with history of vitiligo or sun exposure; 2. Pregnant and lactating women; 3. Patients with sensitive skin and allergies; 4. Patients who are sensitive or allergic to chemical stripping agents; 5. Patients who are currently participating in other clinical studies or have participated in other clinical studies within 3 months.

Design outcomes

Primary

Measure	Time frame
Number of skin lesions;	—

Countries

China

Contacts

Public ContactDongJie Sun

The First Affiliated Hospital of Kunming Medical University

412633947@qq.com+86 13669757601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026